Kristofer Andréasson
1 – 10 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Treatment for Rheumatoid Arthritis Associated With Alterations in the Gastrointestinal Microbiota
(
- Contribution to journal › Article
-
Mark
Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis
(
- Contribution to journal › Article
- 2023
-
Mark
Gastrointestinal tract involvement in systemic sclerosis : The roles of diet and the microbiome
(
- Contribution to journal › Article
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article
-
Mark
Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
(
- Contribution to journal › Article
-
Mark
Systemic sclerosis
(
- Contribution to journal › Scientific review
-
Mark
Is classifying SSc-ILD drugs as either immunosuppressive or anti-fibrotic misleading?
(
- Contribution to journal › Letter
-
Mark
Cohort profile : The Swedish Tattoo and Body Modifications Cohort (TABOO)
(
- Contribution to journal › Article
-
Mark
Systemic sclerosis and primary biliary cholangitis : Longitudinal data to determine the outcomes
(
- Contribution to journal › Article
- 2022
-
Mark
Response to : Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.
(
- Contribution to journal › Debate/Note/Editorial